A detailed history of Canada Pension Plan Investment Board transactions in United Therapeutics Corp stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 29,800 shares of UTHR stock, worth $11.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,800
Previous 180,800 83.52%
Holding current value
$11.9 Million
Previous $41.5 Million 77.15%
% of portfolio
0.01%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$228.26 - $319.04 $34.5 Million - $48.2 Million
-151,000 Reduced 83.52%
29,800 $9.49 Million
Q1 2024

May 14, 2024

BUY
$210.76 - $249.51 $32.4 Million - $38.3 Million
153,700 Added 567.16%
180,800 $41.5 Million
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $2.13 Million - $2.54 Million
9,900 Added 57.56%
27,100 $5.96 Million
Q3 2023

Nov 09, 2023

SELL
$211.82 - $248.24 $1.4 Million - $1.64 Million
-6,600 Reduced 27.73%
17,200 $3.88 Million
Q2 2023

Aug 09, 2023

BUY
$205.19 - $232.99 $1.19 Million - $1.35 Million
5,800 Added 32.22%
23,800 $5.25 Million
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $915,857 - $1.19 Million
-4,300 Reduced 19.28%
18,000 $4.03 Million
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $2.45 Million - $3.34 Million
11,900 Added 114.42%
22,300 $6.2 Million
Q3 2022

Nov 14, 2022

BUY
$203.3 - $244.17 $1.52 Million - $1.83 Million
7,500 Added 258.62%
10,400 $2.18 Million
Q2 2022

Aug 12, 2022

BUY
$174.81 - $241.14 $146,315 - $201,834
837 Added 40.57%
2,900 $683,000
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $238,771 - $307,460
1,437 Added 229.55%
2,063 $371,000
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $115,200 - $135,050
-625 Reduced 49.96%
626 $136,000
Q3 2021

Nov 15, 2021

BUY
$179.86 - $214.88 $73,203 - $87,456
407 Added 48.22%
1,251 $231,000
Q2 2021

Aug 16, 2021

BUY
$170.47 - $211.93 $143,876 - $178,868
844 New
844 $151,000
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $13,392 - $15,211
-87 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$101.87 - $151.79 $821,581 - $1.22 Million
-8,065 Reduced 98.93%
87 $13,000
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $4.94 Million - $5.99 Million
-49,438 Reduced 85.84%
8,152 $823,000
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $4.05 Million - $5.5 Million
-43,710 Reduced 43.15%
57,590 $6.97 Million
Q1 2020

May 13, 2020

BUY
$79.39 - $115.35 $17,227 - $25,030
217 Added 0.21%
101,300 $9.61 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $1.95 Million - $2.37 Million
-24,876 Reduced 19.75%
101,083 $8.9 Million
Q3 2019

Nov 12, 2019

BUY
$74.85 - $85.99 $2.54 Million - $2.91 Million
33,890 Added 36.81%
125,959 $10 Million
Q2 2019

Aug 12, 2019

BUY
$76.06 - $120.81 $1.04 Million - $1.65 Million
13,695 Added 17.47%
92,069 $7.19 Million
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $1.06 Million - $1.25 Million
9,874 Added 14.41%
78,374 $9.2 Million
Q4 2018

Feb 06, 2019

SELL
$101.4 - $128.73 $607,588 - $771,350
-5,992 Reduced 8.04%
68,500 $7.46 Million
Q3 2018

Nov 09, 2018

SELL
$113.81 - $129.46 $5.66 Million - $6.43 Million
-49,700 Reduced 40.02%
74,492 $9.53 Million
Q2 2018

Aug 07, 2018

BUY
$101.14 - $118.31 $5.46 Million - $6.39 Million
54,000 Added 76.93%
124,192 $14.1 Million
Q1 2018

May 14, 2018

BUY
$107.21 - $151.94 $1.18 Million - $1.67 Million
11,000 Added 18.58%
70,192 $7.89 Million
Q4 2017

Feb 14, 2018

BUY
$118.58 - $151.28 $2.56 Million - $3.27 Million
21,600 Added 57.46%
59,192 $8.76 Million
Q3 2017

Oct 30, 2017

SELL
$114.6 - $136.81 $4.25 Million - $5.08 Million
-37,100 Reduced 49.67%
37,592 $4.41 Million
Q2 2017

Jan 31, 2018

BUY
N/A
19,190 Added 34.58%
74,692 $9.69 Million
Q1 2017

Jan 31, 2018

BUY
N/A
55,502
55,502 $7.51 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Canada Pension Plan Investment Board Portfolio

Follow Canada Pension Plan Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.